Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.190ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.120ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AM.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.249ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.505ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.406ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.115ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.133ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.466ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.489ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.363ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.95ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.531ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.200ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.299ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.149ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.300ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.179ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.125ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
G.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.438ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.178ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.208ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.197ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.491ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.8 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.39.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BQ.1.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.75.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBJ.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used